Relation of C-reactive protein and coronary heart disease. Current knowledges;Ruolo della proteina C-reattiva nella patologia coronarica. Attuali conoscenze

Recenti Progressi in Medicina

Volumn 100, Issue 6, 2009, Pages 279-285

  Biasillo, Gina ^a   De Maria, Giovanni Luigi ^a   Leo, Milena ^a   Stefanelli, Antonella ^a   Biasucci, Luigi Marzio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

C reactive protein; Coronary heart disease; Ischaemic cardiopaty

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; PLACEBO; ROSUVASTATIN; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CYTOKINE RELEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; ISCHEMIC HEART DISEASE; PRIMARY PREVENTION; REVIEW; WEIGHT REDUCTION;

C-REACTIVE PROTEIN; CORONARY DISEASE; HUMANS; PROGNOSIS; RISK ASSESSMENT;

EID: 68349114790     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Ross R. Atheroscleorsis: an inflammatory disease. NEJM 1999; 340: 115-126
2. Ross R. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature 1993; 362: 801-809 (Pubitemid 23132154)
3. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-424
4. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-Reactive Protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-860
5. Cianflone D, Ciccirillo F, Buffon A, Trani C, Scabbia EV, Finocchiaro ML, et al. Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris, and in acute myocardial infarction. Am J Cardiol 1995; 76: 215-219
6. Liuzzo G, Biasucci LM, Gallimore JR, Caligiuri G, Buffon A, Rebuzzi AG, et al. Enhanced inflammatory response in patients with pre-infarction unstable angina. J Am Coll Cardiol 1999; 34: 1696-1703
7. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-1186
8. Tillett WS, Francis T. Serologic reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561-571
9. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, et al. C reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. ATVB 1998; 18: 1386-92. (Pubitemid 28421875)
10. Pepys MB, Hirschfield GM. C reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812
11. Marnell L, Mold C, du Clos TW. C reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005; 117: 104-111
12. Devaraj S, O'Keefe G, Jialal I. Defining the pro-inflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab 2005; 90: 4549-4554 (Pubitemid 41159341)
13. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implicatrions for atherosclerosis. Circulation 2001; 103: 1194-1197 (Pubitemid 32221339)
14. Liuzzo G, Santamaria M, Biasucci LM, Narducci M, Colafrancesco V, Porto A, et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 2007; 49: 185-194 (Pubitemid 46054391)
15. Nakagomi A, Freedman SB, Geczy CL. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C reactive protein: relationship with age, sex and hormon replacement treatment. Circulation 2000; 101: 1785-1791 (Pubitemid 30213099)
16. Blaschke F, Bruemmer D, Yin F, Takata Y, Wang W, Fishbein MC, et al. C reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation 2004; 110: 579-587 (Pubitemid 39031176)
17. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and theRural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-1127
18. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843 (Pubitemid 30165206)
19. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733
20. Koenig W, Sund M, Frohlich M, Fischer HG, Lowell H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men:results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study,1984-1992. Circulation 1999; 99: 237-242
21. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor InterventionTrial. Am J Epidemiol 1996; 144: 537-547
22. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20-28 (Pubitemid 40075677)
23. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med 2008; 359: 2195-2207
24. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silber-Shatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32: 2575-2579 (Pubitemid 33055308)
25. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485 (Pubitemid 32433842)
26. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and Troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 Anti-Platelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 2000; 35: 1535-1542
27. Sabatine M, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-st elevation acute coronary syndromes: simultaneous assessment of troponin i, c-reactive protein, and b-type natriuretic peptide. Circulation 2002; 105: 1760-1763 (Pubitemid 34408881)
28. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-1415 (Pubitemid 34263269)
29. Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 1998; 82: 715-719 (Pubitemid 28439629)
30. Lindhal B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000; 343: 1139-1147 (Pubitemid 30781984)
31. Niccoli G, Biasucci LM, Biscione C, Fusco B, Porto I, Leone AM, et al. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2008; 196: 779-785
32. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34: 1512-1521
33. Milazzo D, Biasucci LM, Luciani N, Martinelli L, Canosa C, Schiavello R, et al. Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am J Cardiol 1999; 84: 459-461
34. Walter DH, Fichtlscherer S, Sellwig M, Auchschwelk W, Schachinger V, Zeir AM, et al. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37: 839-846
35. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, et al. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol 2008; 51: 2339-2346 (Pubitemid 351784544)
36. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511. (Pubitemid 36158056)
37. Harb TS, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rifai N, et al. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol 2002; 89: 216-221 (Pubitemid 34132914)
38. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of c-reactive protein. J Am Coll Cardiol 2006; 47: 962-968 (Pubitemid 43312756)
39. Fredrikson GN, Hedbland B, Nilsson JA, Alm R, Berglund G, Nilsson J. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 2004; 53: 1436-1442 (Pubitemid 39410383)
40. Feldman M, Jialal I, Devaraj S, Cryer B. Effects of low dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001; 37: 2036-2041 (Pubitemid 32547994)
41. Woodward M, Lowe GD, Francis LM, Rumley A, Cobbe SM; CADET Study Investigators. A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: The CADET trial. J Thromb Haemost 2004; 11: 1934-1940 (Pubitemid 40192746)
42. Lincoff AM, Kereiakes DJ, Mascelli MA, Deckelbaum LI, Barnathan ES, Patel KK, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001; 104: 163-167
43. Mitrovic V, Klein HH, Krekel N, Kreuzer J, Fichtlscherer S, Schirmer A, et al. Influence of the angiotensin converting enzyme inhibitor ramipril on high sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis. Z Kardiol 2005; 94: 336-342
44. Schieffer B, Bunte C, Witte J, Hoeper K, Böger RH, Schwedhelm E, et al. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol 2004; 44: 362-368 (Pubitemid 38960662)
45. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, et al. C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20-28 (Pubitemid 40075677)
46. Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, et al. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of Defibrillator (CAMI GUIDE) study. J Cardiovasc Med (Hagerstown) 2007; 8: 293-299 (Pubitemid 46586670)
47. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006; 440: 1217-1221